Frequencies of apolipoprotein E alleles in depressed patients undergoing hemodialysis – a case-control study

References

• Yen YC, Rebok GW, Yang MJ, Lung FW. A multilevel analysis of the influence of Apolipoprotein E genotypes on depressive symptoms in late-life moderated by the environment. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:479–486
   PubMed Web of Science ®Google Scholar
• Ibrahim N, Chiew-Thong NK, Desa A, Razali R. Depression and coping in adults undergoing dialysis for end-stage renal disease. Asia Pac Psychiatry. 2013;5(Suppl 1):35–40
   Web of Science ®Google Scholar
• Winkler K, Hoffmann MM, Krane V, Marz W, Drechsler C, Wanner C. Apolipoprotein E genotype predicts cardiovascular endpoints in dialysis patients with type 2 diabetes mellitus. Atherosclerosis. 2010;208:197–202
   PubMed Web of Science ®Google Scholar
• Krishnan KR, Taylor WD, McQuoid DR, et al. Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression. Biol Psychiatry. 2004;55:390–397
   PubMed Web of Science ®Google Scholar
• Weiner DE, Scott TM, Giang LM, et al. Cardiovascular disease and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis. 2011;58:773–781
   PubMed Web of Science ®Google Scholar
• Jung S, Lee YK, Choi SR, Hwang SH, Noh JW. Relationship between cognitive impairment and depression in dialysis patients. Yonsei Med J. 2013;54:1447–1453
   PubMed Web of Science ®Google Scholar
• Agganis BT, Weiner DE, Giang LM, et al. Depression and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis. 2010;56:704–712
   PubMed Web of Science ®Google Scholar
• Winkler K, Hoffmann MM, Krane V, Marz W, Drechsler C, Wanner C. Apolipoprotein E genotype predicts cardiovascular endpoints in dialysis patients with type 2 diabetes mellitus. Atherosclerosis. 2010;208:197–202
   PubMed Web of Science ®Google Scholar
• Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci USA. 2006;103:5644–5651
   PubMed Web of Science ®Google Scholar
• Delano-Wood L, Houston WS, Emond JA, et al. APOE genotype predicts depression in women with Alzheimer's disease: A retrospective study. Int J Geriatr Psychiatry. 2008;23:632–636
   PubMed Web of Science ®Google Scholar
• Mauricio M, O'Hara R, Yesavage JA, et al. A longitudinal study of apolipoprotein-E genotype and depressive symptoms in community-dwelling older adults. Am J Geriatr Psychiatry. 2000;8:196–200
   PubMed Web of Science ®Google Scholar
• Krishnan KR, Hays JC, Blazer DG. MRI-defined vascular depression. Am J Psychiatry. 1997;154:497–501
   PubMed Web of Science ®Google Scholar
• Pimontel MA, Reinlieb ME, Johnert LC, Garcon E, Sneed JR, Roose SP. The external validity of MRI-defined vascular depression. Int J Geriatr Psychiatry. 2013;28:1189–1196
   PubMed Web of Science ®Google Scholar
• Traykov L, Bayle AC, Latour F, et al. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease. J Neurol Sci. 2007;257:280–283
   PubMed Web of Science ®Google Scholar
• Jorge RE, Moser DJ, Acion L, Robinson RG. Treatment of vascular depression using repetitive transcranial magnetic stimulation. Arch Gen Psychiatry. 2008;65:268–276
   PubMed Web of Science ®Google Scholar
• Sun X, Chiu CC, Liebson E, et al. Depression and plasma amyloid beta peptides in the elderly with and without the apolipoprotein E4 allele. Alzheimer Dis Assoc Disord. 2009;23:238–244
   PubMed Web of Science ®Google Scholar
• Drew DA, Weiner DE, Tighiouart H, et al. Cognitive function and all-cause mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2015;65(2):303–311
   PubMed Web of Science ®Google Scholar
• Chiang GC, Zhan W, Schuff N, Weiner MW. White matter alterations in cognitively normal apoE epsilon2 carriers: Insight into Alzheimer resistance. AJNR Am J Neuroradiol. 2012;33:1392–1397
   PubMed Web of Science ®Google Scholar
• Giltay EJ, van Reedt Dortland AK, Nissinen A, et al. Serum cholesterol, apolipoprotein E genotype and depressive symptoms in elderly European men: The FINE study. J Affect Disord. 2009;115:471–477
   PubMed Web of Science ®Google Scholar
• Muller-Thomsen T, Arlt S, Ganzer S, et al. Depression in Alzheimer's disease might be associated with apolipoprotein E epsilon 4 allele frequency in women but not in men. Dement Geriatr Cogn Disord. 2002;14:59–63
   PubMed Web of Science ®Google Scholar
• Rigaud AS, Traykov L, Caputo L, et al. Association of the apolipoprotein E epsilon4 allele with late-onset depression. Neuroepidemiology. 2001;20:268–272
   PubMed Web of Science ®Google Scholar
• Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci USA. 2006;103:5644–5651
   PubMed Web of Science ®Google Scholar
• Yen YC, Rebok GW, Gallo JJ, Yang MJ, Lung FW, Shih CH. ApoE4 allele is associated with late-life depression: A population-based study. Am J Geriatr Psychiatry. 2007;15:858–868
   PubMed Web of Science ®Google Scholar
• Yen YC, Rebok GW, Yang MJ, Lung FW. A multilevel analysis of the influence of Apolipoprotein E genotypes on depressive symptoms in late-life moderated by the environment. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:479–486
   PubMed Web of Science ®Google Scholar
• Chou KL. Moderating effect of apolipoprotein genotype on loneliness leading to depressive symptoms in Chinese older adults. Am J Geriatr Psychiatry. 2010;18:313–322
   PubMed Web of Science ®Google Scholar
• Fan PL, Chen CD, Kao WT, Shu BC, Lung FW. Protective effect of the apo epsilon2 allele in major depressive disorder in Taiwanese. Acta Psychiatr Scand. 2006;113:48–53
   PubMed Web of Science ®Google Scholar
• Carvalho-Wells AL, Jackson KG, Lockyer S, Lovegrove JA, Minihane AM. APOE genotype influences triglyceride and C-reactive protein responses to altered dietary fat intake in UK adults. Am J Clin Nutr. 2012;96:1447–1453
   PubMed Web of Science ®Google Scholar
• Guan S, Yang J, Tang Z, et al. The relationship between apolipoprotein (apo) E polymorphism and lipid changes: An 8-year cohort study in Beijing elderly persons. Arch Gerontol Geriatr. 2012;55:713–717
   PubMed Web of Science ®Google Scholar
• Kingwell BA, Chapman MJ. Future of high-density lipoprotein infusion therapies: Potential for clinical management of vascular disease. Circulation. 2013;128:1112–1121
   PubMed Web of Science ®Google Scholar
• Luciano M. Apolipoprotein E and depressive symptoms: Shared or independent routes to age-related cognitive decline. Psychosom Med. 2014;76:98–100
   PubMed Web of Science ®Google Scholar
• Li ZJ, An X, Mao HP, et al. Association between depression and malnutrition-inflammation complex syndrome in patients with continuous ambulatory peritoneal dialysis. Int Urol Nephrol. 2011;43:875–882
   PubMed Web of Science ®Google Scholar
• Braesch-Andersen S, Paulie S, Smedman C, Mia S, Kumagai-Braesch M. ApoE production in human monocytes and its regulation by inflammatory cytokines. PLoS One. 2013;8:e79908
   Google Scholar